Projects per year
Fingerprint
Dive into the research topics where Ellen L Goode is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Mayo Clinic Ovarian Cancer SPORE
Kaufmann, S. H., Bell, D. A., Bible, K. C., Cliby, W. A., Couch, F. J., Fields, A. P., Galanis, E., Goode, E. L., Haluska, P. R. J., Hartmann, L. C., Karnitz, L. M., Keeney, G., Knutson, K. L., Lengyel, E., Lingle, W. L., Long, H. J., Sherman, M. E., Moriarity, B. S., Oberg, A. L., Peng, K., Shridhar, V. & Weroha, S.
9/1/09 → 8/31/24
Project: Research project
-
-
Mechanisms of Immune Suppression in Ovarian Cancer
Goode, E. L., Hartmann, L. C. & Knutson, K. L.
7/1/09 → 8/31/14
Project: Research project
-
GENETIC LINKAGE IN COLORECTAL CANCER FAMILES
Potter, J. D. & Goode, E. L.
9/20/04 → 6/30/10
Project: Research project
-
CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study
AOCS Group, Mar 1 2023, In: Cancer. 129, 5, p. 697-713 17 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study
AOCS Group, Jan 26 2023, In: British journal of cancer. 128, 1, p. 137-147 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery
on behalf of the Ovarian Cancer Association Consortium, Jan 2023, In: Gynecologic oncology. 168, p. 68-75 8 p.Research output: Contribution to journal › Article › peer-review
-
Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis
AOCS Group, May 8 2023, In: Journal of the National Cancer Institute. 115, 5, p. 539-551 13 p.Research output: Contribution to journal › Article › peer-review
-
Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma
Australian Ovarian Cancer Study Group, Apr 3 2023, In: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 32, 4, p. 542-549 8 p.Research output: Contribution to journal › Article › peer-review